Emergent Biosolutions
EBS
EBS
254 hedge funds and large institutions have $1.81B invested in Emergent Biosolutions in 2021 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 88 increasing their positions, 94 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $2.22B → $1.81B (-$410M)
31% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 68
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
254
Holding in Top 10
–
Calls
$6.64M
Puts
$6.48M
Top Buyers
| 1 | +$97.8M | |
| 2 | +$38.4M | |
| 3 | +$27.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.1M |
| 5 |
Millennium Management
New York
|
+$17.1M |
Top Sellers
| 1 | -$114M | |
| 2 | -$45.5M | |
| 3 | -$22.2M | |
| 4 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
-$21.9M |
| 5 |
Goldman Sachs
New York
|
-$17M |